Article info
PDFClinical science
Five-year visual outcomes after anti-VEGF therapy with or without photodynamic therapy for polypoidal choroidal vasculopathy
- Correspondence to Dr Manabu Miyata, , Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Shogoin Kawahara-cho 54, Sakyo-ku, Kyoto 606-8507, Japan; miyatam{at}kuhp.kyoto-u.ac.jp
Citation
Five-year visual outcomes after anti-VEGF therapy with or without photodynamic therapy for polypoidal choroidal vasculopathy
Publication history
- Received January 22, 2018
- Revised April 6, 2018
- Accepted May 22, 2018
- First published June 6, 2018.
Online issue publication
April 17, 2019
Article Versions
- Previous version (6 June 2018).
- Previous version (29 September 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.